Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

INTRODUCTION: Curcumin is a polyphenolic compound derived from the plant Curcuma Long Lin that has been demonstrated to have antioxidant and anti-inflammatory effects as well as effects on reducing beta-amyloid aggregation. It reduces pathology in transgenic models of Alzheimer's disease (AD) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ringman, John M, Frautschy, Sally A, Teng, Edmond, Begum, Aynun N, Bardens, Jenny, Beigi, Maryam, Gylys, Karen H, Badmaev, Vladimir, Heath, Dennis D, Apostolova, Liana G, Porter, Verna, Vanek, Zeba, Marshall, Gad A, Hellemann, Gerhard, Sugar, Catherine, Masterman, Donna L, Montine, Thomas J, Cummings, Jeffrey L, Cole, Greg M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580400/
https://www.ncbi.nlm.nih.gov/pubmed/23107780
http://dx.doi.org/10.1186/alzrt146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580400/
https://www.ncbi.nlm.nih.gov/pubmed/23107780
http://dx.doi.org/10.1186/alzrt146

Ejemplares similares